6513-20-8Relevant academic research and scientific papers
Pyrrolotriazine-5-carboxylate ester inhibitors of EGFR and HER2 protein tyrosine kinases and a novel one-pot synthesis of C-4 subsitituted pyrrole-2,3-dicarboxylate diesters
Mastalerz, Harold,Gavai, Ashvinikumar V.,Fink, Brian,Struzynski, Charles,Tarrant, James,Vite, Gregory D.,Wong, Tai W.,Zhang, Guifen,Vyas, Dolatrai M.
, p. 528 - 533 (2007/10/03)
Pyrrolotriazines with an ester group at C-5 were prepared and evaluated as inhibitors of the EGFR and HER2 receptor tyrosine kinases, validated targets for cancer therapy. The C-5 ester (15) was at least as potent as its C-6 ester analogue (17), an exampl
3-Pyridyl enantiomers and their use as analgesics
-
, (2008/06/13)
The present invention relates to a method of controlling pain in mammals, including humans, comprising administering to a mammal or patient in need of treatment thereof selected compounds of formula I: STR1 or a pharmaceutically acceptable salt thereof. The invention further relates to selected (R) and (S) compounds of formula I above which are useful as analgesics as well as neuronal cell death preventors and anti-inflammatories.
